+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Semaglutide Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Semaglutide Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Inadequately Controlled Type-II Diabetes Treatment Market Report 2025 - Product Thumbnail Image

Inadequately Controlled Type-II Diabetes Treatment Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Prediabetes Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

Prediabetes Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 184 Pages
  • Global
From
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 184 Pages
  • Global
From
Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Thumbnail Image

Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • January 2025
  • 182 Pages
  • Global
From
Type 2 Diabetes Market 2025-2029 - Product Thumbnail Image

Type 2 Diabetes Market 2025-2029

  • Report
  • February 2025
  • 221 Pages
  • Global
From
Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • July 2025
  • 150 Pages
  • Global
From
Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Prediabetes Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Prediabetes Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Anti-Diabetic Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Diabetic Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 140 Pages
  • Global
From
Type 2 Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Type 2 Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Severe Hypertriglyceridemia Pipeline Analysis Report 2025 - Product Thumbnail Image

Severe Hypertriglyceridemia Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypoglycemia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypoglycemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Thumbnail Image

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 87 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 142 Pages
  • Global
From
Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 90 Pages
  • Global
From
Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 81 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more